NCT05791448View on ClinicalTrials.gov

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 29, 2023

Primary Completion Date

March 29, 2026

Study Completion Date

March 29, 2027

Conditions
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverRefractory Malignant Solid NeoplasmStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Computed Tomography

Undergo CT scan

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

DRUG

RNA Transcription Modulator AU-409

Given PO

Trial Locations (2)

90033

RECRUITING

Los Angeles County-USC Medical Center, Los Angeles

RECRUITING

USC / Norris Comprehensive Cancer Center, Los Angeles

Sponsors

Collaborators (1)

Auransa, Inc.
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Auransa, Inc.

UNKNOWN

lead

University of Southern California

OTHER

NCT05791448 - AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease | Biotech Hunter | Biotech Hunter